Next generation´s test system for faster and more secure biological evaluation of drugs, materials and chemicals

As a Vinnova - Challenge-driven innovation (Utmaningsdriven innovation) – phase 2, the project aims to develop next generation´s test systems for medicinal and medical products by using advanced stem cell technology to create bioreactors for different organs and tissues. These test systems will fill the gap between today´s limited cell culture techniques, animal experiments and clinical trials, thus enabling faster, safer, and more efficient product development. By extension, this will not only strengthen Swedish industry and competitiveness, but also lead to cheaper products which will benefit the health care sector and the society as a whole.

The Sensor System department role is to develop non-invasive optical imaging system for in vivo and real-time monitoring of metabolic activity in growing tissues/organs. We will also support Chalmers University of Technology for building measurement and control system of various parameters in bioreactors for the research of proposed applications.

 

Coordinator: Joakim Håkansson, SP Sveriges Tekniska Forskningsinstitut

Duration: 2014-05-15 to 2016-08-25

Partners: GU (Institute of Biomedicine; Surgery dept. at Sahlgrenska academy; VINN Excellence centre for biomaterial and cell therapy; Pathology dept.), CTH (Microtechnology and nanoscience group), KTH (fibre and polymer technology), NovaHep AB, TATAA Biocenter AB, Bactiguard AB, AstraZeneca AB, Integrum, Västra Götalandsregionen.